Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tubulin aggregation-IN-17 (compound 23g) is a potent inhibitor of tubulin aggregation. tubulin aggregation-IN-17 has a microtubulin-depolymerising effect, induces apoptosis and inhibits migration. tubulin aggregation-IN-17 has potential for cancer disease research. Tubulin aggregation-IN-17 has potential for cancer disease research.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | Tubulin aggregation-IN-17 (compound 23g) is a potent inhibitor of tubulin aggregation. tubulin aggregation-IN-17 has a microtubulin-depolymerising effect, induces apoptosis and inhibits migration. tubulin aggregation-IN-17 has potential for cancer disease research. Tubulin aggregation-IN-17 has potential for cancer disease research. |
Molecular Weight | 429.46 |
Formula | C26H23NO5 |
CAS No. | 2454175-89-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Tubulin polymerization-IN-17 2454175-89-2 inhibitor inhibit